Mirum Pharmaceuticals Inc (MIRM)

Jun 06, 2025

Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? - Yahoo Finance

Jun 06, 2025

Jun 04, 2025

Insider Sell: Saira Ramasastry Sells 8,203 Shares of Mirum Pharm - GuruFocus

Jun 04, 2025

Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 By Investing.com - Investing.com India

Jun 04, 2025

Jun 04, 2025

Mirum Pharmaceuticals director sells shares totaling $377,843 - Investing.com

Jun 04, 2025

Jun 03, 2025

(MIRM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 03, 2025

May 31, 2025

Mirum pharmaceuticals raises 2025 revenue guidance to $435M-$450M driven by robust growth - MSN

May 31, 2025

May 30, 2025

Mirum Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

May 30, 2025

May 30, 2025

Alagille Syndrome Treatment Market Detailed in New Research ReportMirum Pharmaceuticals, Albireo Pharma - openPR.com

May 30, 2025

May 29, 2025

Two Sigma Investments LP Has $5.23 Million Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - MarketBeat

May 29, 2025

May 28, 2025

Man Group plc Invests $289,000 in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 28, 2025

May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential By Investing.com - Investing.com South Africa

May 26, 2025

May 26, 2025

Mirum Pharmaceuticals’ SWOT analysis: rare disease stock shows growth potential - Investing.com Nigeria

May 26, 2025

May 26, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 26, 2025

May 23, 2025

When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com

May 23, 2025

May 22, 2025

Mirum Pharmaceuticals (MIRM) – Research Analysts’ Weekly Ratings Changes - Defense World

May 22, 2025

May 22, 2025

What is HC Wainwright’s Estimate for MIRM Q2 Earnings? - Defense World

May 22, 2025

May 20, 2025

Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer - citybiz

May 20, 2025

May 20, 2025

Comerica Bank Reduces Stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 20, 2025

May 20, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025

May 19, 2025

Mirum Pharmaceuticals Names Doug Sheehy New Chief Legal Officer - Bloomberg Law News

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwri - GuruFocus

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Appoints New Chief Legal Officer | - GuruFocus

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating from HC Wainwright & Co. | MIRM Stock News - GuruFocus

May 19, 2025

May 19, 2025

Mirum Pharmaceuticals (MIRM) Receives Buy Rating with Promising Growth Potential | MIRM Stock News - GuruFocus

May 19, 2025

May 17, 2025

Analysts Set Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Price Target at $60.64 - Defense World

May 17, 2025

May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025

May 15, 2025

Northern Trust Corp Acquires 32,059 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World

May 15, 2025

May 15, 2025

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 15, 2025

May 14, 2025

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

May 14, 2025

May 13, 2025

Mirum Pharmaceuticals (MIRM) Maintains Strong Buy Rating with Ra - GuruFocus

May 13, 2025

May 13, 2025

Mirum Pharmaceuticals (MIRM) Gets Price Target Boost to $77 | MI - GuruFocus

May 13, 2025

May 13, 2025

Trend Tracker for (MIRM) - news.stocktradersdaily.com

May 13, 2025

May 12, 2025

FY2025 EPS Estimates for MIRM Raised by Cantor Fitzgerald - Defense World

May 12, 2025

May 12, 2025

Leerink Partnrs Brokers Increase Earnings Estimates for MIRM - Defense World

May 12, 2025

May 11, 2025

JMP Securities Increases Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $76.00 - Defense World

May 11, 2025

May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Stron - GuruFocus

May 09, 2025

May 09, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

May 09, 2025

May 09, 2025

Beyond The Numbers: 4 Analysts Discuss Mirum Pharmaceuticals Stock - Benzinga

May 09, 2025

May 09, 2025

Mirum Pharmaceuticals (MIRM) Maintains Market Outperform Rating with Higher Price Target | MIRM Stock News - GuruFocus

May 09, 2025

May 09, 2025

Mirum's Q1 Earnings Beat Estimates, 2025 Revenue View Raised - MSN

May 09, 2025

May 09, 2025

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL - Business Wire

May 09, 2025

May 09, 2025

Mirum Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 09, 2025

May 09, 2025

JMP raises Mirum Pharmaceuticals stock target to $76 By Investing.com - Investing.com Canada

May 09, 2025

May 09, 2025

Mirum Pharmaceuticals (MIRM) Price Target Raised Following Strong Revenue Outlook | MIRM Stock News - GuruFocus

May 09, 2025

May 08, 2025

Evercore ISI lifts Mirum stock target to $76, maintains outperform By Investing.com - Investing.com Canada

May 08, 2025

May 08, 2025

Evercore ISI lifts Mirum stock target to $76, maintains outperform - Investing.com

May 08, 2025

May 08, 2025

Mirum Pharmaceuticals Reports Strong Q1 2025 Results - TipRanks

May 08, 2025

May 08, 2025

Earnings call transcript: Mirum Pharmaceuticals beats Q1 2025 revenue forecasts - Investing.com

May 08, 2025

May 07, 2025

Mirum Pharmaceuticals beats Q1 estimates, raises 2025 guidance; shares rise - Investing.com Nigeria

May 07, 2025